JPWO2023092180A5 - - Google Patents
Info
- Publication number
- JPWO2023092180A5 JPWO2023092180A5 JP2024531268A JP2024531268A JPWO2023092180A5 JP WO2023092180 A5 JPWO2023092180 A5 JP WO2023092180A5 JP 2024531268 A JP2024531268 A JP 2024531268A JP 2024531268 A JP2024531268 A JP 2024531268A JP WO2023092180 A5 JPWO2023092180 A5 JP WO2023092180A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- naphthamide
- carbamimidoyl
- pyrazol
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021903789A AU2021903789A0 (en) | 2021-11-24 | Methods of treating sars-cov-2 infection | |
| AU2021903789 | 2021-11-24 | ||
| PCT/AU2022/051405 WO2023092180A1 (en) | 2021-11-24 | 2022-11-24 | Methods of treating sars-cov-2 infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024543259A JP2024543259A (ja) | 2024-11-20 |
| JPWO2023092180A5 true JPWO2023092180A5 (https=) | 2025-11-25 |
| JP2024543259A5 JP2024543259A5 (https=) | 2025-11-25 |
Family
ID=86538440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024531268A Pending JP2024543259A (ja) | 2021-11-24 | 2022-11-24 | ＳＡＲＳ－ＣｏＶ－２感染を治療する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250009713A1 (https=) |
| EP (1) | EP4436576A4 (https=) |
| JP (1) | JP2024543259A (https=) |
| KR (1) | KR20240110039A (https=) |
| CN (1) | CN118574614A (https=) |
| AU (1) | AU2022399231A1 (https=) |
| CA (1) | CA3238183A1 (https=) |
| WO (1) | WO2023092180A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115260100B (zh) * | 2022-08-08 | 2023-12-12 | 赛诺瑞生物医药技术(无锡)有限公司 | 一种用于制备冠状病毒治疗药物的取代酰基胍类化合物和用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ596107A (en) * | 2005-06-24 | 2013-09-27 | Biotron Ltd | Antiviral compounds and methods |
| ES2563477T3 (es) * | 2007-08-03 | 2016-03-15 | Biotron Limited | Composiciones antivirales para tratar la hepatitis C a base de 5-(1-metilpirazol-4-il)2-naftoilguanidina y 2'-C-metiladenosina o 2'-C-metilcitidina |
| SG11201907034PA (en) * | 2017-02-08 | 2019-08-27 | Biotron Ltd | Methods of treating influenza |
| US20220409587A1 (en) * | 2019-11-26 | 2022-12-29 | Biotron Limited | Methods of treating hiv-1 infection |
| US11660307B2 (en) * | 2020-01-27 | 2023-05-30 | Gilead Sciences, Inc. | Methods for treating SARS CoV-2 infections |
| WO2021207049A1 (en) * | 2020-04-06 | 2021-10-14 | Gilead Sciences, Inc. | Inhalation formulations of 1'-cyano substituted carbanucleoside analogs |
-
2022
- 2022-11-24 CN CN202280089709.6A patent/CN118574614A/zh active Pending
- 2022-11-24 AU AU2022399231A patent/AU2022399231A1/en active Pending
- 2022-11-24 CA CA3238183A patent/CA3238183A1/en active Pending
- 2022-11-24 KR KR1020247020169A patent/KR20240110039A/ko active Pending
- 2022-11-24 EP EP22896871.5A patent/EP4436576A4/en active Pending
- 2022-11-24 WO PCT/AU2022/051405 patent/WO2023092180A1/en not_active Ceased
- 2022-11-24 JP JP2024531268A patent/JP2024543259A/ja active Pending
- 2022-11-24 US US18/712,518 patent/US20250009713A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023002662A5 (https=) | ||
| JP2024075655A5 (ja) | 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用 | |
| JP2009514874A5 (https=) | ||
| JP2025020117A5 (https=) | ||
| JP2002528502A5 (https=) | ||
| JP2020523334A5 (https=) | ||
| JP2024545086A (ja) | 抗ウイルス治療剤及びその使用 | |
| JP2008533127A5 (https=) | ||
| CN101654393A (zh) | 作为肝脏保护剂的化合物和组合物 | |
| JP2022177119A5 (https=) | ||
| JPWO2023092180A5 (https=) | ||
| FI4199922T3 (fi) | (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa | |
| JP2025060703A5 (https=) | ||
| JPWO2020178721A5 (https=) | ||
| JPWO2021209739A5 (https=) | ||
| JP2021530568A5 (https=) | ||
| JPWO2021191592A5 (https=) | ||
| JPWO2023043999A5 (https=) | ||
| JPWO2021186151A5 (ja) | Ａｚｄ１６５６又はその薬学的に許容される塩を含む、コロナウイルスによって引き起こされた肺炎及び／又は心筋炎の治療用組成物 | |
| RU2498797C2 (ru) | Комбинированное средство для лечения гриппа и орви | |
| JPWO2021207606A5 (https=) | ||
| JPWO2022040447A5 (https=) | ||
| JPWO2023049731A5 (https=) | ||
| JP2007513095A5 (https=) | ||
| JPWO2022081711A5 (https=) |